Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Alcock

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|March 19, 2010
A group practiceS C ALCOCK
BMJ (Clinical Research Ed.)|February 7, 2001
Treatment of oral cancer. Biopsy under local anaesthetic is inadequateG Cox, C Alcock, R Corbridge
Clinical Radiology|July 1, 1988
The analysis of malignant tumours of uncertain origin with immunohistological techniques: clinical follow-upM Robinson, C Alcock, K C Gatter, et al.
Lancet (London, England)|June 8, 1985
Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniquesK C Gatter, C Alcock, A Heryet, et al.
Nature|November 19, 1992
Lifespan of human lymphocyte subsets defined by CD45 isoformsC A Michie, A McLean, C Alcock, et al.
Annals of the Royal College of Surgeons of England|September 4, 2008
Identification and treatment of anaemia in patients awaiting hip replacementB A Rogers, A Cowie, C Alcock, et al.
British Journal of Cancer|August 1, 1985
The value of immunocytochemical methods in the differential diagnosis of anaplastic thyroid tumoursN Ralfkiaer, K C Gatter, C Alcock, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 6, 2000
Patients with cancer holding their own records: a randomised controlled trialM Drury, P Yudkin, J Harcourt, et al.
BMC Cancer|January 27, 2011
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastomaAmanda Tivnan, Lorraine Tracey, Patrick G Buckley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 19, 2007
The assessment of patients with newly diagnosed head and neck malignancy: can we improve our practice?M Barakate, J Keir, R Corbridge, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|March 19, 2010
A group practiceS C ALCOCK
BMJ (Clinical Research Ed.)|February 7, 2001
Treatment of oral cancer. Biopsy under local anaesthetic is inadequateG Cox, C Alcock, R Corbridge
Clinical Radiology|July 1, 1988
The analysis of malignant tumours of uncertain origin with immunohistological techniques: clinical follow-upM Robinson, C Alcock, K C Gatter, et al.
Lancet (London, England)|June 8, 1985
Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniquesK C Gatter, C Alcock, A Heryet, et al.
Nature|November 19, 1992
Lifespan of human lymphocyte subsets defined by CD45 isoformsC A Michie, A McLean, C Alcock, et al.
Annals of the Royal College of Surgeons of England|September 4, 2008
Identification and treatment of anaemia in patients awaiting hip replacementB A Rogers, A Cowie, C Alcock, et al.
British Journal of Cancer|August 1, 1985
The value of immunocytochemical methods in the differential diagnosis of anaplastic thyroid tumoursN Ralfkiaer, K C Gatter, C Alcock, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 6, 2000
Patients with cancer holding their own records: a randomised controlled trialM Drury, P Yudkin, J Harcourt, et al.
BMC Cancer|January 27, 2011
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastomaAmanda Tivnan, Lorraine Tracey, Patrick G Buckley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 19, 2007
The assessment of patients with newly diagnosed head and neck malignancy: can we improve our practice?M Barakate, J Keir, R Corbridge, et al.
Pageof 2